Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 75-80 , January 2009

Are we underutilizing minimally invasive approaches for upper tract urothelial carcinoma?

  • J. Stuart Wolf Jr., M.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-734-764-8397; fax: +1-734-936-9127

References 

  1. United States Renal Data System Annual Data Report 2007, Mortality Tables. http://www.usrds.org/2007/ref/H_morte_07.pdfAccessed December 28, 2007
  2. Letourneau I, Ouimet D, Dumont M, et al. Renal replacement in end-stage renal disease patients over 75 years old. Am J Nephrol. 2003;23:71–77
  3. Skolarikos A, Griffiths TR, Powell PH, et al. Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment. Urology. 2003;61:1146–1150
  4. Brown GA, Matin SF, Busby JE, et al. Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology. 2007;70:252–256
  5. Lim DJ, Shattuck MC, Cook WA. Pyelovenous lymphatic migration of transitional cell carcinoma following flexible ureterorenoscopy. J Urol. 1993;149:109–111
  6. Kulp DA, Bagley DH. Does flexible ureteropyeloscopy promote local recurrence of transitional cell carcinoma?. J Endourol. 1994;8:111–113
  7. Hendin BH, Streem SB, Levin HS, et al. Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol. 1999;161:783–785
  8. Boorjian S, Ng C, Munver R, et al. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma. Urology. 2005;66:283–287
  9. Lee BR, Jabbour ME, Marshall FF, et al. Thirteen-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: Equivalent outcomes. J Endourol. 1999;13:289–294
  10. Roupret M, Hupertan V, Traxer O, et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology. 2006;67:1181–1187
  11. Elliott DS, Segura JW, Lightner D, et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? (Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney). Urology. 2001;58:174–178
  12. Keeley FX, Bibbo M, Bagley DH. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol. 1997;157:1560–1565
  13. Daneshmand S, Quek ML, Huffman JL. Endoscopic management of upper urinary tract transitional cell carcinoma: Long term experience. Cancer. 2003;98:55–60
  14. Deligne E, Colombel M, Badet L, et al. Conservative management of upper urinary tract tumors. Eur Urol. 2002;42:43–48
  15. Elliott DS, Blute ML, Pattersons DE, et al. Long term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology. 1996;47:819–825
  16. Goel MC, Mahendra V, Roberts JG. Percutaneous management of renal pelvic urothelial tumors: Long term followup. J Urol. 2003;169(3):925–929
  17. Suh RS, Faerber GJ, Wolf JS. Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J Urol. 2003;170:2209–2216
  18. Weizer AZ, Faerber GJ, Wolf JS. Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. Urology. 2007;70:469–472

PII: S1078-1439(08)00080-X

doi: 10.1016/j.urolonc.2008.04.006

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 75-80 , January 2009

Article Tools

* Image Usage & Resolution